Sign In
Buy PFE
$25.69
+0.335 (+1.32%)
At Close: Jun 04, 2026
Pfizer Earnings Preview: Pharma May Plumb New Depths After Obesity Drug Debacle
01:52pm, Wednesday, 23'rd Apr 2025
Pfizer Inc.'s stock has performed poorly despite massive COVID-19 earnings, trading at a 12-year low due to flawed M&A deals and high debt levels. The discontinuation of danuglipron, a potential obesi
2 High-Yield Dividend Stocks to Buy for Passive Income
08:30am, Wednesday, 23'rd Apr 2025
Passive income is essential in retirement, but building a dependable stream isn't easy. Fortunately, top-tier dividend stocks can do the heavy lifting.
Pfizer Stock Before Q1 Earnings Release: To Buy or Not to Buy?
08:00am, Wednesday, 23'rd Apr 2025
PFE's non-COVID drugs and contributions from new and newly acquired products are likely to have driven top-line growth in the first quarter.
What's Next for Pfizer After the Company Pulls Its Weight Loss Drug?
06:40am, Wednesday, 23'rd Apr 2025
The anti-obesity drug market has the potential to be massive, with multiple analysts projecting it may reach at least $100 billion by 2030. As a result, many top healthcare companies are vying for a p
S&P 500 Sell-Off: 2 Ultra-High-Yield Dividend Stocks That Make for No-Brainer Buys
03:51am, Wednesday, 23'rd Apr 2025
Though the stock market is a bona fide wealth creator for those who exercise patience and perspective, it's not an investment vehicle that gets from Point A to B in a straight line.
Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom
11:13am, Tuesday, 22'nd Apr 2025
Trump's tariff policy is the latest uncertainty to plague the pharmaceutical sector.
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
11:06am, Tuesday, 22'nd Apr 2025
Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
10:05am, Tuesday, 22'nd Apr 2025
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Pfizer Inc. (NYSE: PFE) Price Prediction and Forecast 2025-2030 (April 2025)
02:54pm, Monday, 21'st Apr 2025
Shares of Pfizer ( NYSE: PFE ) have been battered over the past month, falling by -16.44%, outpacing the market's loss of -9.44% over the same period.
3 High Yielding Dividend Stocks Near 52-Week Lows
11:20am, Monday, 21'st Apr 2025
2025 hasn't been kind to investors amid rising concerns about a recession and tariffs.
LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed
09:00am, Monday, 21'st Apr 2025
The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week. This is especially true with LLY, as you will see on the charts.
Pfizer: Is The Dividend Yield Worth The Effort
03:55am, Monday, 21'st Apr 2025
Despite its historical underperformance and declining dividend growth trajectory, Pfizer's 7.63% dividend yield is attractive, making it a compelling income stock candidate. CEO Bourla's strategic foc
3 Ultra-High-Yield Dividend Stocks to Buy Right Now That Are Dirt Cheap
05:45am, Sunday, 20'th Apr 2025
Every cloud has a silver lining. Sometimes, they have two.
3 Magnificent Stocks to Buy That Are Near 52-Week Lows
08:30am, Saturday, 19'th Apr 2025
It's been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties over the effect of sweeping changes in trade policy under the Trump administrat
If You Like Schwab's SCHD, You Can't Miss These Stocks With Even Higher Yields
10:39am, Friday, 18'th Apr 2025
The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) has a reputation for being the go-to choice for income-focused investors who want both quality and yield.
